Dimitry SA Nuyten - Sep 15, 2024 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role
Chief Medical Officer
Signature
/s/ Carolyn Tang, Attorney-in-Fact
Stock symbol
RCUS
Transactions as of
Sep 15, 2024
Transactions value $
-$96,661
Form type
4
Date filed
9/17/2024, 06:42 PM
Previous filing
Jan 25, 2024
Next filing
Dec 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCUS Common Stock Tax liability -$96.7K -5.39K -5.37% $17.95 94.9K Sep 15, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
F2 Includes 1,123 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan.